SYNERGEN FILES REGISTRATION STATEMENT FOR 3,000,000 SHARES OF COMMON STOCK
SYNERGEN FILES REGISTRATION STATEMENT
FOR 3,000,000 SHARES OF COMMON STOCK
BOULDER, Colo., Nov. 7 /PRNewswire/ -- Synergen Inc. (NASDAQ: SYGN) announced today that it has filed a registration statement with the Securities and Exchange Commission for the proposed sale by the company of 3,000,000 shares of its Common Stock. Alex. Brown & Sons Inc. and Robertson, Stephens & Co. are co-managing the offering.
The company expects to use the net proceeds from the proposed offering for working capital and other general corporate purposes.
Synergen is a biopharmaceutical company engaged in the discovery, development and manufacture of protein-based pharmaceuticals.
/NOTE: A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
/CONTACT: Debra Catz Bannister of Synergen, 303-938-6242/
(SYGN) CO: Synergen Inc. ST: Colorado IN: MTC SU: SG -- DV004 -- 2237 11/07/91 12:46 EST